CINACALCET

Generic: CINACALCET

Camber PharmaceuticalsManufacturer
ORALRoute
CINACALCET HYDROCHLORIDEActive Substance
2020-10-07Original Approval

CINACALCET is FDA application ANDA209403, sponsored by HETERO LABS LTD V. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2026-03-16
Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga,

CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit

Class II2024-01-18
Cinacalcet Tablets 60mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury,

CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufactu

Class II2026-03-16
Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga,

CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit

Class II2026-06-29
Cinacalcet Hydrochloride Tablets, 30 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India;

cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).

Class II2024-10-10
Cinacalcet Tablets, 90 mg, Rx Only, a) 30 Tablets per bottle, NDC: 16729-442-10, b) 90 Tablets per bottle, NDC: 16729-44

CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable

Class II2024-10-09
Cinacalcet Tablets, 90 mg, 30-count bottle, Rx Only, Dr. Reddy's Laboratories Inc, Princeton, NJ 08540, Made in India.,

CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit

Class II2025-11-14
Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independe

CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable

Class II2025-11-14
Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independe

CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable

Class II2026-06-29
Cinacalcet Hydrochloride Tablets, 90 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India;

cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).

Class II2026-06-29
Cinacalcet Hydrochloride Tablets, 60 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India;

cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).

Top Reported Reactions

1
DEATH
436 reports
2
OFF LABEL USE
395 reports
3
DRUG INEFFECTIVE
365 reports
4
HYPOCALCAEMIA
273 reports
5
NAUSEA
228 reports
6
VOMITING
203 reports
7
HYPERCALCAEMIA
189 reports
8
DIARRHOEA
184 reports
9
ACUTE KIDNEY INJURY
150 reports
10
CALCIPHYLAXIS
140 reports